About
Oneg HaKarmel (OHK MED) Ltd. is an Israeli medical device company founded in 1999 and located in Tirat Carmel. The company develops and manufactures innovative devices for critical care medicine, notably in the segment of blood loss in limb surgery and the emergency management of severe hemorrhagic shock (SHS) and cardiac arrest (CA). Their business model focuses on developing innovative products, strong regulatory compliance, strategic partnerships, and a dedicated team. Oneg Hakarmel's core patent-protected technology is a line of single-use devices designed to quickly and effectively displace blood from the limbs and block its re-entry. OHK Medical Devices is ISO 13845 certified to develop and manufacture medical devices. Their products are manufactured in Israel and China and shipped from logistics centers in Haifa, Amsterdam, and California. Over 1.5 million products have been distributed in 48 countries and used in leading hospitals on 5 continents.
Headcount over time
Q&A
- What is Oneg Hakarmel's primary business?
- Oneg Hakarmel manufactures and sells products for orthopedic surgery, vascular surgery, and emergency medicine, focusing on single-use devices to displace blood from limbs and block its re-entry.
- What is the core technology behind Oneg Hakarmel's products?
- The core patent-protected technology is a line of single-use devices designed to quickly and effectively displace blood from the limbs and block its re-entry.
- What is the HemaClear product line used for?
- The HemaClear line of sterile surgical products is widely used to create a bloodless surgical field during surgery.
- What is the EED product line designed for?
- The EED product line is for use in emergency medicine to auto-transfuse a patient's own blood from their limbs into central circulation during severe shock or cardiopulmonary resuscitation.
- When did Oneg Hakarmel launch HemaShock and what is its purpose?
- In November 2018, Oneg Hakarmel launched HemaShock, an emergency auto-transfusion tourniquet used to squeeze blood out of the limbs and block arterial blood flow re-entry, indicated for patients with very low systolic blood pressure due to hemodynamic shock or cardiac arrest.
- What regulatory approvals does HemaClear have?
- HemaClear is FDA listed and CE marked.
- How many employees does Oneg Hakarmel have?
- Oneg Hakarmel has 11-50 employees.
- Where is Oneg Hakarmel headquartered?
- Oneg Hakarmel is headquartered in Tirat Carmel, Israel.
Team · 1
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | hemaclear.com |
|---|---|
| linkedin.com/company/147009 | |
| facebook.com/HemaClear | |
| YouTube | youtube.com/user/TheHemaClear |
Identifiers & details
| Legal name | Oneg Hakarmel Ltd. |
|---|---|
| Founded | 1999 |
| Employees (exact) | 29 |
| Offices | Mnster; Grandville |
Radar intelligence
Patents
| EPO | 8 |
|---|
Publications (Crossref)
| Works | 1 |
|---|
Web history (Wayback)
| Domain | hemaclear.com |
|---|
Certificate / subdomain footprint
| Subdomains | 14 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 512810474 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 1999-07-27 |
| Purpose | לעסוק בסוגי עיסוק שפורטו בתקנון |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2024 |
| Active charges / liens | 0 |
| Registry events | 5 — shares_capital (1), charge (1), other (1), people (2) |
| Registered address | אתגר 4 טירת כרמל |
Recent registry events
| Date | Event |
|---|---|
| 2026-06-30 | העברת מניות |
| 2025-07-24 | סילוק שעבוד |
| 2025-10-21 | עדכון כתובת ו/או מען דיגיטלי |
| 2025-10-15 | עדכון דירקטורים-הסרת דירקטור |
| 2025-10-05 | עדכון בעלי תפקידים |